Breast tissue composition and susceptibility to breast cancer.
Breast density, as assessed by mammography, reflects breast tissue composition. Breast epithelium and stroma attenuate x-rays more than fat and thus appear light on mammograms while fat appears dark. In this review, we provide an overview of selected areas of current knowledge about the relationship between breast density and susceptibility to breast cancer. We review the evidence that breast density is a risk factor for breast cancer, the histological and other risk factors that are associated with variations in breast density, and the biological plausibility of the associations with risk of breast cancer. We also discuss the potential for improved risk prediction that might be achieved by using alternative breast imaging methods, such as magnetic resonance or ultrasound. After adjustment for other risk factors, breast density is consistently associated with breast cancer risk, more strongly than most other risk factors for this disease, and extensive breast density may account for a substantial fraction of breast cancer. Breast density is associated with risk of all of the proliferative lesions that are thought to be precursors of breast cancer. Studies of twins have shown that breast density is a highly heritable quantitative trait. Associations between breast density and variations in breast histology, risk of proliferative breast lesions, and risk of breast cancer may be the result of exposures of breast tissue to both mitogens and mutagens. Characterization of breast density by mammography has several limitations, and the uses of breast density in risk prediction and breast cancer prevention may be improved by other methods of imaging, such as magnetic resonance or ultrasound tomography.
Boyd
Norman F
NF
Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Room 10-415 610 University Ave, Toronto, ON, Canada M5G2M9. boyd@uhnres.utoronto.ca
Martin
Lisa J
LJ
Bronskill
Michael
M
Yaffe
Martin J
MJ
Duric
Neb
N
Minkin
Salomon
S
D001940:Breast / Q000473:pathology*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000235:genetics / Q000378:metabolism / Q000473:pathology* / Q000517:prevention & control; D015986:Confounding Factors, Epidemiologic; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D015994:Incidence; D008279:Magnetic Resonance Imaging; D008327:Mammography; D008934:Mitogens / Q000009:adverse effects; D009153:Mutagens / Q000009:adverse effects; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012307:Risk Factors; D018433:Twin Studies as Topic; D016217:Ultrasonography, Mammary; D014481:United States / Q000453:epidemiology
D008934:Mitogens; D009153:Mutagens